Explore more publications!

Press Releases

Medical school enrollment surpasses 100,000 for first time

Medical school enrollment surpasses 100,000 for first time

Saxena White P.A. Files Securities Fraud Class Action Against Integer Holdings Corporation and Certain of Its Executives
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
We Just Do The Opposite: How Insurance By Heroes Is Rebuilding Trust in the Life Insurance Industry
Krown Technologies & ExeQuantum File Joint Patent for SiFA, a New Cryptographic Layer to Stop Email & Payments Fraud
Diligence Care Plus Empowers Families to Thrive During the Holidays; Releases Free Holiday Mental Health Wellness Guide
Krown Technologies and ExeQuantum Announce Joint Patent for SiFA, a Breakthrough Crypto Authentication Layer Technology
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
NOV Announces Sale of Advanced Nuclear Development Company Shepherd Power to Natura Resources in Stock for Stock Transaction
Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4)
INSP INVESTOR ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Attorney General James and Bipartisan Coalition Urge Big Tech Companies to Address Dangerous AI Chatbot Features

Attorney General James and Bipartisan Coalition Urge Big Tech Companies to Address Dangerous AI Chatbot Features

Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome
Hearing Wrap Up: Innovative Technology Can Lower Healthcare Costs for Americans

Hearing Wrap Up: Innovative Technology Can Lower Healthcare Costs for Americans

Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025
Balchem Corporation Announces Dividend

Balchem Corporation Announces Dividend

Burlison Opens Hearing on Technology Lowering the Cost of Healthcare

Burlison Opens Hearing on Technology Lowering the Cost of Healthcare

Grothman Opens Hearing on Technology Lowering the Cost of Healthcare

Grothman Opens Hearing on Technology Lowering the Cost of Healthcare

Unlimited Heart and Nudj Health Expand Whole-Person AF Care Globally, Introducing the AFibulous Human-Experience Model

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions